X-Linked Myotubular Myopathy and Mitochondrial Function in Muscle and Liver Samples

Abstract

X-linked myotubular myopathy (XLMTM) is a rare congenital myopathy that commonly manifests with liver involvement. In most XLMTM cases, disease-causing variants have been identified in the myotubularin gene (MTM1) on chromosome Xq28, which encodes myotubularin protein (MTM1). The impairment of mitochondrial respiratory chain (MRC) enzyme activity in muscle has been observed in the XLMTM mouse model. Though several reports mentioned possible mechanisms of liver involvement in XLMTM patients and animal models, the precise underlying mechanisms remain unknown, and there is no report focused on mitochondrial functions in hepatocytes in XLMTM. We encountered two patients with XLMTM who had liver involvement. We measured MRC enzyme activities in two muscle biopsy specimens, and one liver specimen from our patients to investigate whether MTM1 variants cause MRC dysfunction and whether mitochondrial disturbance is associated with organ dysfunction. MRC enzyme activities decreased in skeletal muscles but were normal in the liver. In our patients, the impaired MRC enzyme activity found in muscle is consistent with previously reported mechanisms that the loss of MTM1-desmin intermediate filament and MTM1-IMMT (a mitochondrial membrane protein) interaction led to the mitochondrial dysfunction. However, our study showed that liver involvement in XLMTM may not be associated with mitochondrial dysfunction.

Keywords

X-linked myotubular myopathy - myotubularin protein - liver involvement - mitochondrial respiratory chain enzyme activity - mitochondrial dysfunction

Contributors' Statements

K.I.: examined and treated the patients, drafted the initial manuscript, and approved the final manuscript as submitted.

T.K.: performed the initial analyses, reviewed and revised the manuscript, and approved the final manuscript as submitted.

E.T.: performed the initial analyses, reviewed and revised the manuscript, and approved the final manuscript as submitted.

M.I.: performed the initial analyses, reviewed and revised the manuscript, and approved the final manuscript as submitted.

T.F.: performed the initial analyses, reviewed and revised the manuscript, and approved the final manuscript as submitted.

Y.A.: measured enzyme activity, reviewed and revised the manuscript, and approved the final manuscript as submitted.

K.M.: measured enzyme activity, reviewed and revised the manuscript, and approved the final manuscript as submitted.

All the authors approved the final manuscript as submitted and agreed to be accountable for all aspects of the work.

Publication History

Received: 11 March 2024

Accepted: 22 June 2024

Article published online:
15 July 2024

• References

• 1 Blondeau F, Laporte J, Bodin S, Superti-Furga G, Payrastre B, Mandel JL. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum Mol Genet 2000; 9 (15) 2223-2229
• 2 Dowling JJ, Vreede AP, Low SE. et al. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet 2009; 5 (02) e1000372
• 3 Hnia K, Tronchère H, Tomczak KK. et al. Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle. J Clin Invest 2011; 121 (01) 70-85
• 4 Fetalvero KM, Yu Y, Goetschkes M. et al. Defective autophagy and mTORC1 signaling in myotubularin null mice. Mol Cell Biol 2013; 33 (01) 98-110
• 5 Herman GE, Finegold M, Zhao W, de Gouyon B, Metzenberg A. Medical complications in long-term survivors with X-linked myotubular myopathy. J Pediatr 1999; 134 (02) 206-214
• 6 Kirby DM, Crawford M, Cleary MA, Dahl HH, Dennett X, Thorburn DR. Respiratory chain complex I deficiency: an underdiagnosed energy generation disorder. Neurology 1999; 52 (06) 1255-1264
• 7 Murayama K, Nagasaka H, Tsuruoka T. et al. Intractable secretory diarrhea in a Japanese boy with mitochondrial respiratory chain complex I deficiency. Eur J Pediatr 2009; 168 (03) 297-302
• 8 Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002; 59 (09) 1406-1411
• 9 Etienne-Manneville S. Cytoplasmic intermediate filaments in cell biology. Annu Rev Cell Dev Biol 2018; 34: 1-28
• 10 Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol 2000; 150 (06) 1283-1298
• 11 Capetanaki Y, Milner DJ. Desmin cytoskeleton in muscle integrity and function. Subcell Biochem 1998; 31: 463-495
• 12 Reipert S, Steinböck F, Fischer I, Bittner RE, Zeöld A, Wiche G. Association of mitochondria with plectin and desmin intermediate filaments in striated muscle. Exp Cell Res 1999; 252 (02) 479-491
• 13 Dayal AA, Medvedeva NV, Nekrasova TM, Duhalin SD, Surin AK, Minin AA. Desmin interact directly with mitochondria. Int J Mol Sci 2020; 21 (21) 8122
• 14 Saks VA, Kuznetsov AV, Khuchua ZA. et al. Control of cellular respiration in vivo by mitochondrial outer membrane and by creatine kinase. A new speculative hypothesis: possible involvement of mitochondrial-cytoskeleton interactions. J Mol Cell Cardiol 1995; 27 (01) 625-645
• 15 Capetanaki Y. Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. Trends Cardiovasc Med 2002; 12 (08) 339-348
• 16 Sarikaya E, Sabha N, Volpatti J. et al. Natural history of a mouse model of X-linked myotubular myopathy. Dis Model Mech 2022; 15 (07) dmm049342
• 17 Dowling JJ, Müller-Felber W, Smith BK. et al; INCEPTUS investigators. INCEPTUS natural history, run-in study for gene replacement clinical trial in X-linked myotubular myopathy. J Neuromuscul Dis 2022; 9 (04) 503-516
• 18 Shieh PB, Kuntz NL, Dowling JJ. et al. Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial. Lancet Neurol 2023; 22 (12) 1125-1139
• 19 Molera C, Sarishvili T, Nascimento A. et al. Intrahepatic cholestasis is a clinically significant feature associated with natural history of X-linked myotubular myopathy (XLMTM):　a case series and biopsy report. J Neuromuscul Dis 2022; 9 (01) 73-82
• 20 Funayama K, Shimizu H, Tanaka H. et al. An autopsy case of peliosis hepatis with X-linked myotubular myopathy. Leg Med (Tokyo) 2019; 38: 77-82
• 21 Hagiwara S, Kubota M, Sakaguchi K, Hiwatari E, Kishimoto H, Kagimoto S. Fatal hepatic hemorrhage from peliosis hepatis with X-linked myotubular myopathy. J Pediatr Gastroenterol Nutr 2015; 60 (05) e45-e46
• 22 Karolczak S, Deshwar AR, Aristegui E. et al. Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy. J Clin Invest 2023; 133 (18) e166275